Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2002
03/14/2002WO2002019822A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
03/14/2002WO2002019814A2 Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety
03/14/2002WO2002019813A2 Method of obtaining a non-human mammal susceptible to adenovirus-mediated gene delivery
03/14/2002WO2002019812A2 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor
03/14/2002WO2002019811A2 Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage
03/14/2002WO2002019803A1 Disease-resistant plants and method of constructing the same
03/14/2002WO2002011548A8 Means for extending the shelf-life of vegetables
03/14/2002WO2001096564A3 Hla-g (hla-g7) isoform and its applications
03/14/2002WO2001090189A3 G-protein coupled receptor org3.
03/14/2002WO2001081600A3 Transgenic plants
03/14/2002WO2001081581A3 Compositions and methods for the therapy and diagnosis of acne vulgaris
03/14/2002WO2001081357A3 Method for indirectly extracting non-cultivable dna organisms and dna obtainable by said method
03/14/2002WO2001080901A3 Gene directed enzyme prodrug therapy (gdept) for cell ablation
03/14/2002WO2001079506A3 Treatment of ocular neovascularization and related diseases
03/14/2002WO2001079505A3 INHIBITION OF BONE TUMOR FORMATION USING ANTISENSE cDNA THERAPY
03/14/2002WO2001079502A3 Vectors for gene therapy
03/14/2002WO2001078655A3 Methods and compositions for heat shock protein mediated immunotherapy of melanoma
03/14/2002WO2001077358A3 Herpes viruses for immune modulation
03/14/2002WO2001077352A3 Vectors and method for selecting cdna molecules, which comprise an open reading frame
03/14/2002WO2001077320A3 Regulation of human hm74-like g protein coupled receptor
03/14/2002WO2001077147A3 New bromodomain protein
03/14/2002WO2001075131A3 Expression of uncoupling protein (ucp) in plants
03/14/2002WO2001074861A3 Compositions and methods for tissue specific gene regulation therapy
03/14/2002WO2001073092A3 Interspecific dianthus plant
03/14/2002WO2001073075A3 Muskmelon cucumis melo hydroperoxide lyase and uses thereof
03/14/2002WO2001070986A3 Helical protein zalpha51
03/14/2002WO2001070944A3 Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene.
03/14/2002WO2001070929A3 Transgenic plants containing heat shock protein
03/14/2002WO2001070805A3 Soluble mast cell function associated antigen (mafa) pharmaceutical compositions and methods of making and using them
03/14/2002WO2001070768A3 Receptor-binding compounds and method for identifying them
03/14/2002WO2001069200A3 Methods for detection of differences in nucleic acids
03/14/2002WO2001068882A3 Methods for homologous recombination
03/14/2002WO2001068881A3 Dna sequence and a method for the in vivo marking and the analysis of dna/chromatin in cells
03/14/2002WO2001068836A3 Methods and compositions for rna interference
03/14/2002WO2001066749A3 A member of the lectin superfamily
03/14/2002WO2001066717A3 Gene targeting method
03/14/2002WO2001066696A3 Stable cell lines resistant to apoptosis and nutrient stress and methods of making same
03/14/2002WO2001066694A3 Method for transferring material in a cell system
03/14/2002WO2001066554A3 Solid phase synthesis method and reagent
03/14/2002WO2001066149A3 Nucleic acid formulations for gene delivery and methods of use
03/14/2002WO2001064920A3 Hybrid expression of neisserial proteins
03/14/2002WO2001064902A3 46867, a transferase family member and uses therefor
03/14/2002WO2001062969A3 Estrogen receptor alpha variants and methods of detection thereof
03/14/2002WO2001062377A3 Microarray fabrication techniques and apparatus
03/14/2002WO2001061046A3 HUMAN VNO cDNA LIBRARIES
03/14/2002WO2001061011A3 Human thrombospondin repeat proteins and polynucleotides encoding the same
03/14/2002WO2001061007A3 Fibroblast growth factor-23 molecules and uses thereof
03/14/2002WO2001061001A3 Novel, central nervous protein, that modulates k+ flows
03/14/2002WO2001060978A3 In ovo activation of an avian egg in the shell
03/14/2002WO2001059129A3 Mammalian secreted group iii phospholipase a2
03/14/2002WO2001059126A3 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility
03/14/2002WO2001059064A3 Nucleic acids, proteins, and antibodies
03/14/2002WO2001058921A9 Methods and compositions for generating angiostatin
03/14/2002WO2001058918A3 Oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments
03/14/2002WO2001057085A3 G-protein coupled receptors
03/14/2002WO2001057081A3 Narc-1, subtilase-like homologs
03/14/2002WO2001057080A3 Neuropeptide-like polypeptide zpep17
03/14/2002WO2001055410A3 Ceramidase compositions and methods based thereon
03/14/2002WO2001055392A3 Nuclear hormone receptors
03/14/2002WO2001055358A3 Phosphodiesterases
03/14/2002WO2001055312A3 Nucleic acids, proteins, and antibodies
03/14/2002WO2001055198A3 Dermo- and gastro-specific sphingolipid activator
03/14/2002WO2001051519A3 Potassium channel mutants of the saccharomyces cerevisiae yeast and the use thereof for the screening of eukaryotic potassium channels
03/14/2002WO2001051512A3 Human and parasite orphan receptor proteins
03/14/2002WO2001048162A3 Method for the production of vitamin a
03/14/2002WO2001046412A3 Interaction proteins for the stat transcription factor
03/14/2002WO2001044497A3 Protein kinase regulation
03/14/2002WO2001042508A3 Methods and compositions relating to electrical detection of nucleic acid reactions
03/14/2002WO2001042290A3 Novel steroid-activated nuclear receptors and uses therefor
03/14/2002WO2001040472A3 Streptococcus pneumoniae antigens
03/14/2002WO2001036684A3 Mammalian toxicological response markers
03/14/2002WO2001027267A3 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions
03/14/2002WO2001025444A3 Novel human phosphodiesterase zcytor13
03/14/2002WO2001023572A3 Polynucleotides and polypeptides encoded thereby
03/14/2002WO2001023001A3 Rapid peg-modification
03/14/2002WO2001021651A3 Novel human protease inhibitor-like proteins and polynucleotides encoding the same
03/14/2002WO2001020031A3 Polymorphisms in a klotho gene
03/14/2002WO2001012788A3 Tryptase-like polypeptide ztryp1
03/14/2002WO2000066743A9 Viral expression vectors
03/14/2002WO2000063441A3 Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease
03/14/2002WO2000060083A9 Novel protein associated with cell stress response
03/14/2002WO2000058483A9 Protozoan expression system
03/14/2002WO2000056927A3 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
03/14/2002WO2000056899A9 Dsp-2 dual-specificity map kinase phosphatase
03/14/2002WO2000055353A9 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system
03/14/2002WO2000055335A9 Pseudotyped lentiviral vectors and uses thereof
03/14/2002WO2000053742A9 Polynucleotides and proteins encoded thereby
03/14/2002WO2000052047A9 Human dickkopf-related protein and nucleic acid molecules and uses therefor
03/14/2002WO2000049557A9 Computer-implemented nucleic acid isolation method and apparatus
03/14/2002WO1997003998A9 Modulators of the function of fas receptors and other proteins
03/14/2002US20020032919 Transgenic plant; for use in food processing
03/14/2002US20020032918 Alteration of growth and adaptation under hypoxic conditions
03/14/2002US20020032917 Scarecrow gene, promoter and uses thereof
03/14/2002US20020032915 Detecting size defect in animal infants; obtain tissue biopsy, monitor expression of somatomedins in sample, amplified somatomedin concentration indicates potential size defect in animals
03/14/2002US20020032914 Transgenic mice containing ubiquitin-specific protease 16 gene disruptions
03/14/2002US20020032913 Gene Search Vector and Gene Search Method
03/14/2002US20020032912 Detecting modulators of transcriotional activity; obtain genetically engineered cells, expose to modulators, evaluate reporter gene expression
03/14/2002US20020032324 Process for the preparation of endotoxin-free or endotoxin-depleted nucleic acids and/or oligonucleotides for gene therapy
03/14/2002US20020032323 Polynucleotide and polypeptide sequence information stored on computer readable media
03/14/2002US20020032321 Novel human transporter proteins and polynucleotides encoding the same
1 ... 2860 2861 2862 2863 2864 2865 2866 2867 2868 2869 2870 2871 2872 2873 2874 2875 2876 2877 2878 2879 2880 ... 4023